Developer docs
API playgroundTry for free, no card

Search company profiles

Vetnil

Full company profile

uuid000if8p

Namestring
Vetnil
Legal namestring
Vetnil
Websiteurl
vetnil.com.br
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Vetnil is a privately-held Brazilian veterinary pharmaceutical company headquartered in Louveira, São Paulo, that develops, manufactures, and distributes medications, nutritional supplements, and dermocosmetics across three primary animal segments: companion animals (dogs, cats, birds, rodents, mustelids, reptiles), equines, and production animals (poultry, cattle, goats/sheep, swine, ostriches). Its portfolio of more than 100 SKUs spans NSAIDs (Firocoxib gel, Meloxinew injectable), antimicrobials (Doxiciclina injectable — the only IV doxycycline available in Brazil), antiparasitics (Doraequi Plus, Vetmax Plus), joint regenerators (Condroton with Chondroitin Sulfate A + Glucosamine + Perna canaliculus + collagen stack), probiotic/symbiotic supplements (ProbioUp line with 7-10 billion CFU formulations), cardiac medications (Pimocor / pimobendan), dermatologicals (Skin Care line), regenerative medicine (Bio Cell by Vetnil stem cell therapy), and the premium JCR equine line (Mioguard JCR, Tonnus Vaq JCR). Annual production capacity is approximately 2,000 tons, and products are manufactured under regulatory approvals at the Louveira facility (now with a LEED Silver-certified logistics center inaugurated in 2024).

Vetnil generates revenue primarily through unit-priced sales of one-time-purchase pharmaceutical and supplement SKUs, distributed via a multi-tier channel model: an authorized distributor network across 15+ international markets (Latin America, UAE, Qatar, Slovenia, Angola), domestic Brazilian distributors reaching veterinary clinics and pet shops, agricultural supply stores for production-animal products, and a direct-to-consumer e-commerce storefront at pertinhodemim.com. Pricing is set at the channel-partner level rather than disclosed publicly. Go-to-market combines professional community engagement (Voz Equestre and Vetnil podcasts, annual Encontro de Residentes veterinary education event with 600+ attendees, scientific symposiums at major congresses), heavy event sponsorship (CAT Congress, CBA, Potro do Futuro ABQM, Eduvet, Latin American Veterinary Conference), and a content library (technical blog, YouTube channels, newsletter). Vetnil's customer base is long-tail and diversified across pet owners, equine veterinarians and breeders, and livestock producers, with no anchor-customer dependency evidenced.

The company is 100% Brazilian-owned, led by President Vera Godoy Ribeiro following the passing of founder Dr. João Carlos Ribeiro, with a workforce of approximately 253 employees as of 2020 and a stable management team spanning marketing, finance (CFO Beatriz Cavalli Gasparini), and equine segment leadership. Vetnil has consistently ranked among Brazil's top veterinary product companies in the Globo Rural Agribusiness Yearbook (1st place Animal Health 2018; 1st place Veterinary Products 2016; Champion 2011) and has held Great Place to Work certifications (7th in Agribusiness 2021). Disclosed revenue was R$ 116 million in 2017 (up from R$ 86.5M in 2016 and R$ 64.46M in 2014), with a reported pattern of year-over-year revenue doubling through the preceding decade.

Short descriptiontext

Vetnil is a privately-held Brazilian veterinary pharmaceutical company that manufactures and distributes 100+ medications, supplements, and dermocosmetics for companion animals, equines, and production animals, reaching customers in Brazil and 15+ international markets via authorized distributors and a DTC e-commerce storefront.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersLouveira, Brazil
HQ citystring
Louveira
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary pharmaceuticals, animal health products, equine supplements, pet medications, veterinary nutraceuticals
Industry5 codes
PRIMARYHLAMAEAM
Generic & Private-Label Veterinary Pharmaceuticals
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAIAH
Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)
SECONDARYHLAMAEAG
Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAH
Dermatology & Allergy Drugs
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMALAE
Immune Support Supplements
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Animal Food Manufacturing3111
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Veterinary Pharmaceuticals
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Veterinary Pharmaceuticals (Medicamentos)
TypeOne Time License
Description

Vetnil manufactures and sells prescription and non-prescription veterinary medications including anti-inflammatories (Firocoxib, Meloxicam), antimicrobials (Doxycycline injectable), antiparasitics (Vetmax Plus, Doraequi Plus), and cardiac medications (Pimocor). Products are classified as medicamentos (medicines) and are distributed through veterinary clinics, pet shops, and agricultural supply stores.

vetnil.com.br
2Nutritional and Dietary Supplements (Suplementos)
TypeOne Time License
Description

Vetnil produces and sells a broad portfolio of nutritional supplements across pet (dogs, cats, birds, rodents, mustelids, reptiles), equine (Traditional Line and JCR Super Premium Line), and production animal segments (poultry, cattle, goats/sheep, swine, ostriches). Includes joint supplements (Condroton), probiotics (ProbioUp line), muscle recovery (Mioguard JCR), and performance supplements.

vetnil.com.br
3Dermo-cosmetic and Hygiene Products (Higiene e Embelezamento)
TypeOne Time License
Description

Vetnil offers dermatological and hygiene products including the Skin Care line (Defense spray, Clean spray, Hidrat serum) for dogs and cats, and Optivet Clean for periocular hygiene. These products address skin health, coat quality, and hygiene needs.

vetnil.com.br
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Veterinary Medications (Medicamentos)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products sold as individual units (bottles, blister packs, tubes, syringes) through distributors and retail. Specific price points not publicly disclosed.

vetnil.com.br
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Bio Cell by Vetnil
Description

Stem cell therapy and regenerative medicine brand for veterinary treatment

vetnil.com.br
+5 more records
Core offering1 text field

Vetnil manufactures and commercializes veterinary pharmaceuticals and nutritional supplements for three segments: companion animals (dogs, cats, birds, rodents, mustelids, reptiles), equines, and production animals (poultry, cattle, goats/sheep, swine, ostriches). The portfolio of more than 100 products spans prescription and OTC medications (NSAIDs, antimicrobials, antiparasitics, cardiac drugs), joint and cartilage supplements, probiotics and symbiotics, dermocosmetics, and regenerative stem cell therapy services. Annual production capacity is approximately 2,000 tons of medications, with distribution in Brazil and 15+ export markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 56% reduction in energy consumption at the new logistics center in Louveira (LEED Silver certified, inaugurated 2024)
+2 more records
Product overview1 text field

Vetnil is a Brazilian veterinary pharmaceutical company offering medications and supplements for companion animals (pets), equines, and production animals. The product portfolio is organized into three main segments: (1) Pet products covering dogs, cats, birds, rodents, mustelids, and reptiles with medications, supplements, and hygiene/beautification items; (2) Equine products split into the Super Premium JCR Line (high-performance supplements like Tonnus® Vaq JCR, Mioguard® JCR) and Traditional Line (medications like Firocoxib Vetnil® Gel, antiparasitics like Doraequi Plus®, and supplements like Equi Up M.O.®); and (3) Production Animals covering poultry, ostriches, cattle, goats/sheep, and swine. Key product categories include joint regenerators (Condroton®), anti-inflammatories (Firocoxib, Meloxinew®), dermatologicals (Skin Care line), intestinal health supplements (ProbioUp line: Dog Imune®, Cat Imune®, Simbio®), dewormers (Vetmax® Plus), cardiac medications (Pimocor®), and stem cell therapy (Bio Cell by Vetnil). The company also offers a Premium dermocosmetics line for pets.

Product and service11 records
1Condroton®
CategoryVeterinary joint supplement (pet)
Description

Joint regenerator with Chondroitin Sulfate A (20,000mg/100g) and Glucosamine (30,000mg/100g) for dogs, indicated for treatment of non-infectious arthropathies such as arthritis, arthrosis, osteoarthrosis, hip dysplasia, and post-operative joint surgery. Available in 500mg or 1000mg tablets.

2Condroton® Plus
CategoryVeterinary joint supplement (equine)
Description

Chondroprotector and joint regenerator medication with Chondroitin Sulfate and MSM for equines, used for general arthropathies, tendon diseases, post-operative joint surgery, and prevention of osteoarticular diseases.

3Firocoxib Vetnil® Gel
CategoryVeterinary anti-inflammatory (equine)
Description

Selective non-steroidal anti-inflammatory (NSAID) for COX-2 indicated for equines, providing anti-inflammatory and analgesic effects.

4Equi Up M.O.®
CategoryVeterinary nutritional supplement (equine)
Description

Nutritional supplement for equines that aids in body condition recovery and supports athletic and working horses.

5Doraequi Plus®
CategoryVeterinary antiparasitic (equine)
Description

Broad-spectrum antiparasitic association for equines, providing parasite control through a novel formulation.

6Tonnus® Vaq JCR
CategoryVeterinary performance supplement (equine)
Description

Equine supplement containing Amino acids, Creatine, HMB, Betaine and Nucleotides, designed to provide strength and performance in competitions. Part of the JCR Super Premium line.

7Mioguard® JCR
CategoryVeterinary performance supplement (equine)
Description

Muscle recovery and fatigue reduction supplement for equine athletes. Contains dimethylglycine (DMG) at the highest concentration in the market. Certified NO DOPING by the International Equestrian Federation (FEI).

8Vetnil® Skin Care Defense
CategoryVeterinary dermocosmetic (pet)
Description

Dermosupplementation spray for dogs and cats that supports skin health and coat condition.

9Vetnil® Skin Care Clean
CategoryVeterinary dermocosmetic (pet)
Description

Spray for hygiene and care of skin of dogs and cats, formulated with Chamomile Extract, Calendula and Aloe Vera.

10Vetnil® Skin Care Hidrat
CategoryVeterinary dermocosmetic (pet)
Description

Serum for hydration of skin and coat of dogs and cats.

11Doxiciclina Vetnil Solução Injetável
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-01
Description

Bio Cell by Vetnil is Vetnil's proprietary stem cell therapy initiative focused on regenerative veterinary medicine. Led by Dr. Patricia Malard (CEO), a pioneer in stem cell validation for animals, Bio Cell develops and applies cell therapy technologies for equines and other animals. The initiative was featured prominently at CAT Congress with a dedicated booth space, and Dr. Malard appeared as a guest on the Voz Equestre podcast discussing stem cell applications in equine medicine.

2Invetsa (Inversiones Veterinarias S.A.)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Official distributor of Vetnil products in Peru. Invetsa partnered with Vetnil at the Latin American Veterinary Conference 2022 in Lima (June 5-8), the largest veterinary congress in Peru with 3,000+ participants. Vetnil's technical promoter gave lectures at the event on animal recovery.

vetnil.com.br
3Sadenir S.A.
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive distributor of Vetnil in Uruguay. Co-organized an online veterinary lecture on nutrition of hospitalized patients with Vetnil, UDELAR university, and FVET veterinary clinic. Vetnil's commercial manager Marcos Mieres at Sadenir emphasized the partnership's commitment to veterinary education.

vetnil.com.br
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Official distributor of Vetnil in Paraguay. Partnered with Vetnil at the 1st Eduvet International Congress in Asunción, Paraguay (September 7-8), the first international veterinary congress bringing together professionals, academics, and specialists at national and international level.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Vetnil maintains authorized distributors across 15+ countries: Costa Rica (AGEAGRO), Paraguay (Agro-Veterinaria Central), Angola (ARCAM), Slovenia (BTL Marketing), Nicaragua (CAPUTILIRA), Chile (Gabrica Chile), Colombia (Gabrica SAS), Guatemala (Grupo Bigor), UAE (Gulf Rider), Qatar (Gulf Rider), Dominican Republic (Hospital Arroyo Hondo), Ecuador (Ilianza), Peru (Invetsa), Mexico (Mederi Lab), Bolivia (Multiagro), Panama (Refarmil), Uruguay (Sadenir).

6Casa do Vira-Lata
Strategic tierMinorTypeOthers
Description

Animal welfare NGO based in São Paulo (Guarulhos and Ferraz de Vasconcelos) that rescues and facilitates adoption of abandoned dogs and cats. Vetnil partnered with Casa do Vira-Lata during CAT Congress 2026, donating artwork from the 'Vestígios' exhibition to support construction of the Casa dos Gatos shelter. Directed by Gabriel Santos Chaves.

vetnil.com.br
7Casa dos Gatos (via Casa do Vira-Lata)
Strategic tierMinorTypeOthers
Description

Cat shelter being constructed by Casa do Vira-Lata. Vetnil donated artwork from the 'Vestígios: a delicadeza de habitar junto' exhibition (by artist Carol Smocowisk) at CAT Congress to fundraise for the shelter's construction.

vetnil.com.br
Strategic tierMinorTypeOthers
Description

Charitable non-profit organization in Louveira, São Paulo, founded in 2017, providing habilitation and rehabilitation for people with intellectual disabilities, multiple disabilities, and autism. Vetnil supports the 'Projeto Voa Bia' equestrian therapy project that benefits patients with Autism Spectrum Disorder.

9Carol Smocowisk
Strategic tierMinorTypeOthers
Description

Brazilian artist who created the 'Vestígios: a delicadeza de habitar junto' exhibition at Vetnil's CAT Congress 2026 booth. The series depicted marks of coexistence between cats and humans. Artworks were donated to Casa do Vira-Lata after the event, with one piece also raffled among congress participants.

vetnil.com.br
Strategic tierMinorTypeOthers
Description

Non-profit NGO focused on research, education, and public policy promotion for the conservation of anteaters, armadillos, and sloths in Brazil, both in the wild and captivity. Part of Vetnil's citizenship and sustainability initiative.

Strategic tierMinorTypeOthers
Description

Initiative promoting scientific research and training for early breast cancer detection using trained dogs' sense of smell. In a test with 130 volunteer patients and two Belgian shepherd dogs, achieved 100% accuracy. Founded by French Institut Curie and brought to Brazil by Leandro Lopes, Dr. Carla Ismael, and Dr. Christian Domenge. Part of Vetnil's citizenship and sustainability program.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Ourofino Saúde Animal
TypeDirect peer
Description

Brazilian animal health company manufacturing and distributing veterinary pharmaceuticals, vaccines, and parasiticides for livestock and companion animals. Most direct domestic competitor to Vetnil, with overlapping categories (antiparasitics, anti-inflammatories, supplements) and similar channel mix of distributors, agro retail, and veterinary clinics.

TypeBroad incumbent
Description

World's largest pure-play animal health company with broad portfolio across companion animal and livestock pharmaceuticals, vaccines, diagnostics, and parasiticides. Competes head-on with Vetnil in NSAIDs, joint health, dermatology, and parasiticide categories, particularly as Zoetis expands in Latin American emerging markets.

3Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Global animal health leader following the Merial acquisition, with strong parasiticides, vaccines, and therapeutics franchises. Competes with Vetnil in core categories and has been actively investing in Latin American markets.

TypeBroad incumbent
Description

Global animal health company offering companion animal therapeutics, parasiticides, and livestock products. Following the Bayer Animal Health acquisition, Elanco is among the top three global players and a direct competitor to Vetnil in pet pharma and livestock categories.

TypeBroad incumbent
Description

French animal health company specializing in companion animal pharmaceuticals, vaccines, and parasiticides with strong presence in Latin America and other emerging markets. Overlaps with Vetnil in dermatology, joint supplements, and small-animal therapeutics.

6Agener União (Eurofarma)
TypeDirect peer
Description

Brazilian veterinary division of Eurofarma, manufacturing and distributing veterinary pharmaceuticals and biologicals for companion animals and livestock. Direct domestic peer to Vetnil in the Brazilian animal health market.

TypeBroad incumbent
Description

Independent French animal health company focused on companion animal and livestock pharmaceuticals with strong equine heritage. Closely comparable to Vetnil given its dedicated equine product line and Latin American commercial presence.

TypeBroad incumbent
Description

Global French animal health company offering pharmaceuticals, vaccines, and equipment for companion animals and livestock. Competes with Vetnil in companion animal therapeutics and reproductive/livestock categories.

TypeBroad incumbent
Description

UK-based specialty animal health company focused on companion animal endocrinology, dermatology, and critical care therapeutics. Comparable to Vetnil in niche specialty therapeutics such as cardiac (Pimocor vs. Vetmedin), dermatology, and joint health.

TypeBroad incumbent
Description

Animal health division of Merck & Co., one of the largest global animal health players, with broad companion animal and livestock portfolios. Competes with Vetnil across nearly all categories and is a frequent benchmark for category leadership.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vetnil

Veterinary Pharmaceuticalsvetnil.com.br

Vetnil is a privately-held Brazilian veterinary pharmaceutical company that manufactures and distributes 100+ medications, supplements, and dermocosmetics for companion animals, equines, and production animals, reaching customers in Brazil and 15+ international markets via authorized distributors and a DTC e-commerce storefront.

What Vetnil does

Vetnil is a privately-held Brazilian veterinary pharmaceutical company headquartered in Louveira, São Paulo, that develops, manufactures, and distributes medications, nutritional supplements, and dermocosmetics across three primary animal segments: companion animals (dogs, cats, birds, rodents, mustelids, reptiles), equines, and production animals (poultry, cattle, goats/sheep, swine, ostriches). Its portfolio of more than 100 SKUs spans NSAIDs (Firocoxib gel, Meloxinew injectable), antimicrobials (Doxiciclina injectable — the only IV doxycycline available in Brazil), antiparasitics (Doraequi Plus, Vetmax Plus), joint regenerators (Condroton with Chondroitin Sulfate A + Glucosamine + Perna canaliculus + collagen stack), probiotic/symbiotic supplements (ProbioUp line with 7-10 billion CFU formulations), cardiac medications (Pimocor / pimobendan), dermatologicals (Skin Care line), regenerative medicine (Bio Cell by Vetnil stem cell therapy), and the premium JCR equine line (Mioguard JCR, Tonnus Vaq JCR). Annual production capacity is approximately 2,000 tons, and products are manufactured under regulatory approvals at the Louveira facility (now with a LEED Silver-certified logistics center inaugurated in 2024).

Vetnil generates revenue primarily through unit-priced sales of one-time-purchase pharmaceutical and supplement SKUs, distributed via a multi-tier channel model: an authorized distributor network across 15+ international markets (Latin America, UAE, Qatar, Slovenia, Angola), domestic Brazilian distributors reaching veterinary clinics and pet shops, agricultural supply stores for production-animal products, and a direct-to-consumer e-commerce storefront at pertinhodemim.com. Pricing is set at the channel-partner level rather than disclosed publicly. Go-to-market combines professional community engagement (Voz Equestre and Vetnil podcasts, annual Encontro de Residentes veterinary education event with 600+ attendees, scientific symposiums at major congresses), heavy event sponsorship (CAT Congress, CBA, Potro do Futuro ABQM, Eduvet, Latin American Veterinary Conference), and a content library (technical blog, YouTube channels, newsletter). Vetnil's customer base is long-tail and diversified across pet owners, equine veterinarians and breeders, and livestock producers, with no anchor-customer dependency evidenced.

The company is 100% Brazilian-owned, led by President Vera Godoy Ribeiro following the passing of founder Dr. João Carlos Ribeiro, with a workforce of approximately 253 employees as of 2020 and a stable management team spanning marketing, finance (CFO Beatriz Cavalli Gasparini), and equine segment leadership. Vetnil has consistently ranked among Brazil's top veterinary product companies in the Globo Rural Agribusiness Yearbook (1st place Animal Health 2018; 1st place Veterinary Products 2016; Champion 2011) and has held Great Place to Work certifications (7th in Agribusiness 2021). Disclosed revenue was R$ 116 million in 2017 (up from R$ 86.5M in 2016 and R$ 64.46M in 2014), with a reported pattern of year-over-year revenue doubling through the preceding decade.

Vetnil firmographics

Firmographics
Name
Vetnil
Legal name
Vetnil
Website
https://vetnil.com.br
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
251–500 employees
Short description
Vetnil is a privately-held Brazilian veterinary pharmaceutical company that manufactures and distributes 100+ medications, supplements, and dermocosmetics for companion animals, equines, and production animals, reaching customers in Brazil and 15+ international markets via authorized distributors and a DTC e-commerce storefront.
Ownership category
akta.pro rank

Vetnil industry classification

Industry
Product category
Veterinary Pharmaceuticals
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Animal Food Manufacturing (3111)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAMAEAM
Generic & Private-Label Veterinary Pharmaceuticals
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAIAH
Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)
SECONDARYHLAMAEAG
Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAH
Dermatology & Allergy Drugs
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMALAE
Immune Support Supplements

Keywords

  • Veterinary pharmaceuticals
  • Animal health products
  • Equine supplements
  • Pet medications
  • Veterinary nutraceuticals

Where Vetnil is headquartered

Location

Headquarters

HQ city
Louveira
HQ country
Brazil
HQ region
Latin America

Offices2 records

Markets served

Vetnil business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Veterinary Pharmaceuticals (Medicamentos): Vetnil manufactures and sells prescription and non-prescription veterinary medications including anti-inflammatories (Firocoxib, Meloxicam), antimicrobials (Doxycycline injectable), antiparasitics (Vetmax Plus, Doraequi Plus), and cardiac medications (Pimocor). Products are classified as medicamentos (medicines) and are distributed through veterinary clinics, pet shops, and agricultural supply stores.
  2. Nutritional and Dietary Supplements (Suplementos): Vetnil produces and sells a broad portfolio of nutritional supplements across pet (dogs, cats, birds, rodents, mustelids, reptiles), equine (Traditional Line and JCR Super Premium Line), and production animal segments (poultry, cattle, goats/sheep, swine, ostriches). Includes joint supplements (Condroton), probiotics (ProbioUp line), muscle recovery (Mioguard JCR), and performance supplements.
  3. Dermo-cosmetic and Hygiene Products (Higiene e Embelezamento): Vetnil offers dermatological and hygiene products including the Skin Care line (Defense spray, Clean spray, Hidrat serum) for dogs and cats, and Optivet Clean for periocular hygiene. These products address skin health, coat quality, and hygiene needs.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goVeterinary Medications (Medicamentos)

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Vetnil product offering

Product offering

Core offering

Vetnil manufactures and commercializes veterinary pharmaceuticals and nutritional supplements for three segments: companion animals (dogs, cats, birds, rodents, mustelids, reptiles), equines, and production animals (poultry, cattle, goats/sheep, swine, ostriches). The portfolio of more than 100 products spans prescription and OTC medications (NSAIDs, antimicrobials, antiparasitics, cardiac drugs), joint and cartilage supplements, probiotics and symbiotics, dermocosmetics, and regenerative stem cell therapy services. Annual production capacity is approximately 2,000 tons of medications, with distribution in Brazil and 15+ export markets.

Product overview

Vetnil is a Brazilian veterinary pharmaceutical company offering medications and supplements for companion animals (pets), equines, and production animals. The product portfolio is organized into three main segments: (1) Pet products covering dogs, cats, birds, rodents, mustelids, and reptiles with medications, supplements, and hygiene/beautification items; (2) Equine products split into the Super Premium JCR Line (high-performance supplements like Tonnus® Vaq JCR, Mioguard® JCR) and Traditional Line (medications like Firocoxib Vetnil® Gel, antiparasitics like Doraequi Plus®, and supplements like Equi Up M.O.®); and (3) Production Animals covering poultry, ostriches, cattle, goats/sheep, and swine. Key product categories include joint regenerators (Condroton®), anti-inflammatories (Firocoxib, Meloxinew®), dermatologicals (Skin Care line), intestinal health supplements (ProbioUp line: Dog Imune®, Cat Imune®, Simbio®), dewormers (Vetmax® Plus), cardiac medications (Pimocor®), and stem cell therapy (Bio Cell by Vetnil). The company also offers a Premium dermocosmetics line for pets.

Differentiator

Problem solved

Functional benefit

Brands

  • Bio Cell by Vetnil: Stem cell therapy and regenerative medicine brand for veterinary treatment
  • Vetnil Skin Care
  • JCR Line (Super Premium)
  • Linha Tradicional
  • ProbioUp
  • Condroton

Products and services

  • Condroton® Joint regenerator with Chondroitin Sulfate A (20,000mg/100g) and Glucosamine (30,000mg/100g) for dogs, indicated for treatment of non-infectious arthropathies such as arthritis, arthrosis, osteoarthrosis, hip dysplasia, and post-operative joint surgery. Available in 500mg or 1000mg tablets.
  • Condroton® Plus Chondroprotector and joint regenerator medication with Chondroitin Sulfate and MSM for equines, used for general arthropathies, tendon diseases, post-operative joint surgery, and prevention of osteoarticular diseases.
  • Firocoxib Vetnil® Gel Selective non-steroidal anti-inflammatory (NSAID) for COX-2 indicated for equines, providing anti-inflammatory and analgesic effects.
  • Equi Up M.O.® Nutritional supplement for equines that aids in body condition recovery and supports athletic and working horses.
  • Doraequi Plus® Broad-spectrum antiparasitic association for equines, providing parasite control through a novel formulation.
  • Tonnus® Vaq JCR Equine supplement containing Amino acids, Creatine, HMB, Betaine and Nucleotides, designed to provide strength and performance in competitions. Part of the JCR Super Premium line.
  • Mioguard® JCR Muscle recovery and fatigue reduction supplement for equine athletes. Contains dimethylglycine (DMG) at the highest concentration in the market. Certified NO DOPING by the International Equestrian Federation (FEI).
  • Vetnil® Skin Care Defense Dermosupplementation spray for dogs and cats that supports skin health and coat condition.
  • Vetnil® Skin Care Clean Spray for hygiene and care of skin of dogs and cats, formulated with Chamomile Extract, Calendula and Aloe Vera.
  • Vetnil® Skin Care Hidrat Serum for hydration of skin and coat of dogs and cats.
  • Doxiciclina Vetnil Solução Injetável

Quantifiable outcome

  • 56% reduction in energy consumption at the new logistics center in Louveira (LEED Silver certified, inaugurated 2024)
  • +2 more outcomes

Companies that use Vetnil

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Vetnil technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Vetnil partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • Bio Cell by VetnilcoreStrategic or Co-development Partner · 1 June 2026Bio Cell by Vetnil is Vetnil's proprietary stem cell therapy initiative focused on regenerative veterinary medicine. Led by Dr. Patricia Malard (CEO), a pioneer in stem cell validation for animals, Bio Cell develops and applies cell therapy technologies for equines and other animals. The initiative was featured prominently at CAT Congress with a dedicated booth space, and Dr. Malard appeared as a guest on the Voz Equestre podcast discussing stem cell applications in equine medicine.
  • Invetsa (Inversiones Veterinarias S.A.)coreChannel Partner/ Reseller/ DistributorOfficial distributor of Vetnil products in Peru. Invetsa partnered with Vetnil at the Latin American Veterinary Conference 2022 in Lima (June 5-8), the largest veterinary congress in Peru with 3,000+ participants. Vetnil's technical promoter gave lectures at the event on animal recovery.
  • Sadenir S.A.coreChannel Partner/ Reseller/ DistributorExclusive distributor of Vetnil in Uruguay. Co-organized an online veterinary lecture on nutrition of hospitalized patients with Vetnil, UDELAR university, and FVET veterinary clinic. Vetnil's commercial manager Marcos Mieres at Sadenir emphasized the partnership's commitment to veterinary education.
  • Agro-Veterinaria Central S.R.L.coreChannel Partner/ Reseller/ DistributorOfficial distributor of Vetnil in Paraguay. Partnered with Vetnil at the 1st Eduvet International Congress in Asunción, Paraguay (September 7-8), the first international veterinary congress bringing together professionals, academics, and specialists at national and international level.
  • International Distributor Network (15 countries)coreChannel Partner/ Reseller/ DistributorVetnil maintains authorized distributors across 15+ countries: Costa Rica (AGEAGRO), Paraguay (Agro-Veterinaria Central), Angola (ARCAM), Slovenia (BTL Marketing), Nicaragua (CAPUTILIRA), Chile (Gabrica Chile), Colombia (Gabrica SAS), Guatemala (Grupo Bigor), UAE (Gulf Rider), Qatar (Gulf Rider), Dominican Republic (Hospital Arroyo Hondo), Ecuador (Ilianza), Peru (Invetsa), Mexico (Mederi Lab), Bolivia (Multiagro), Panama (Refarmil), Uruguay (Sadenir).
  • Casa do Vira-LataminorOthersAnimal welfare NGO based in São Paulo (Guarulhos and Ferraz de Vasconcelos) that rescues and facilitates adoption of abandoned dogs and cats. Vetnil partnered with Casa do Vira-Lata during CAT Congress 2026, donating artwork from the 'Vestígios' exhibition to support construction of the Casa dos Gatos shelter. Directed by Gabriel Santos Chaves.
  • Casa dos Gatos (via Casa do Vira-Lata)minorOthersCat shelter being constructed by Casa do Vira-Lata. Vetnil donated artwork from the 'Vestígios: a delicadeza de habitar junto' exhibition (by artist Carol Smocowisk) at CAT Congress to fundraise for the shelter's construction.
  • APAE LouveiraminorOthersCharitable non-profit organization in Louveira, São Paulo, founded in 2017, providing habilitation and rehabilitation for people with intellectual disabilities, multiple disabilities, and autism. Vetnil supports the 'Projeto Voa Bia' equestrian therapy project that benefits patients with Autism Spectrum Disorder.
  • Carol SmocowiskminorOthersBrazilian artist who created the 'Vestígios: a delicadeza de habitar junto' exhibition at Vetnil's CAT Congress 2026 booth. The series depicted marks of coexistence between cats and humans. Artworks were donated to Casa do Vira-Lata after the event, with one piece also raffled among congress participants.
  • Instituto Tamanduá (Instituto de Pesquisa e Conservação de Tamanduás do Brasil)minorOthersNon-profit NGO focused on research, education, and public policy promotion for the conservation of anteaters, armadillos, and sloths in Brazil, both in the wild and captivity. Part of Vetnil's citizenship and sustainability initiative.
  • Kdog BrasilminorOthersInitiative promoting scientific research and training for early breast cancer detection using trained dogs' sense of smell. In a test with 130 volunteer patients and two Belgian shepherd dogs, achieved 100% accuracy. Founded by French Institut Curie and brought to Brazil by Leandro Lopes, Dr. Carla Ismael, and Dr. Christian Domenge. Part of Vetnil's citizenship and sustainability program.

Scale indicators9 records

Recent moves8 records

Expansion highlights5 records

Vetnil competitors and assessment

Company assessment

Direct peers

  • Ourofino Saúde Animal: Brazilian animal health company manufacturing and distributing veterinary pharmaceuticals, vaccines, and parasiticides for livestock and companion animals. Most direct domestic competitor to Vetnil, with overlapping categories (antiparasitics, anti-inflammatories, supplements) and similar channel mix of distributors, agro retail, and veterinary clinics.
  • Agener União (Eurofarma): Brazilian veterinary division of Eurofarma, manufacturing and distributing veterinary pharmaceuticals and biologicals for companion animals and livestock. Direct domestic peer to Vetnil in the Brazilian animal health market.

Broad incumbents

  • Zoetis: World's largest pure-play animal health company with broad portfolio across companion animal and livestock pharmaceuticals, vaccines, diagnostics, and parasiticides. Competes head-on with Vetnil in NSAIDs, joint health, dermatology, and parasiticide categories, particularly as Zoetis expands in Latin American emerging markets.
  • Boehringer Ingelheim Animal Health: Global animal health leader following the Merial acquisition, with strong parasiticides, vaccines, and therapeutics franchises. Competes with Vetnil in core categories and has been actively investing in Latin American markets.
  • Elanco Animal Health: Global animal health company offering companion animal therapeutics, parasiticides, and livestock products. Following the Bayer Animal Health acquisition, Elanco is among the top three global players and a direct competitor to Vetnil in pet pharma and livestock categories.
  • Virbac: French animal health company specializing in companion animal pharmaceuticals, vaccines, and parasiticides with strong presence in Latin America and other emerging markets. Overlaps with Vetnil in dermatology, joint supplements, and small-animal therapeutics.
  • Vetoquinol: Independent French animal health company focused on companion animal and livestock pharmaceuticals with strong equine heritage. Closely comparable to Vetnil given its dedicated equine product line and Latin American commercial presence.
  • Ceva Santé Animale: Global French animal health company offering pharmaceuticals, vaccines, and equipment for companion animals and livestock. Competes with Vetnil in companion animal therapeutics and reproductive/livestock categories.
  • Dechra Pharmaceuticals: UK-based specialty animal health company focused on companion animal endocrinology, dermatology, and critical care therapeutics. Comparable to Vetnil in niche specialty therapeutics such as cardiac (Pimocor vs. Vetmedin), dermatology, and joint health.
  • MSD Animal Health (Merck Animal Health): Animal health division of Merck & Co., one of the largest global animal health players, with broad companion animal and livestock portfolios. Competes with Vetnil across nearly all categories and is a frequent benchmark for category leadership.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Vetnil social profiles

Digital presence

Vetnil compliance and trust

Trust signal

Compliance2 records

Vetnil financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vetnil leadership team

Management profile

Number of profiles

Profiles8 records

Vetnil subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Vetnil funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vetnil M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vetnil

What does Vetnil do?

Vetnil manufactures and commercializes veterinary pharmaceuticals and nutritional supplements for three segments: companion animals (dogs, cats, birds, rodents, mustelids, reptiles), equines, and production animals (poultry, cattle, goats/sheep, swine, ostriches). The portfolio of more than 100 products spans prescription and OTC medications (NSAIDs, antimicrobials, antiparasitics, cardiac drugs), joint and cartilage supplements, probiotics and symbiotics, dermocosmetics, and regenerative stem cell therapy services. Annual production capacity is approximately 2,000 tons of medications, with distribution in Brazil and 15+ export markets.

Is Vetnil a public or private company?

Vetnil is a private company. It is classified as family owned and is currently operating.

When was Vetnil founded?

Vetnil was founded in 2000. It employs 251 to 500 people.

Where is Vetnil based?

Vetnil is headquartered in Louveira, Brazil, in the Latin America region.

How does Vetnil make money?

Three revenue lines are on record. Veterinary Pharmaceuticals (Medicamentos) is the primary driver. The others are nutritional and Dietary Supplements (Suplementos) and dermo-cosmetic and Hygiene Products (Higiene e Embelezamento).

Who are Vetnil's main competitors?

Direct peers on record are Ourofino Saúde Animal and Agener União (Eurofarma). Broad incumbents are Zoetis, Boehringer Ingelheim Animal Health, Elanco Animal Health, Virbac, Vetoquinol, Ceva Santé Animale, Dechra Pharmaceuticals and MSD Animal Health (Merck Animal Health).

Does Vetnil have an API?

No public API is recorded for Vetnil.

What industry is Vetnil in?

Vetnil's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAM, Generic & Private-Label Veterinary Pharmaceuticals, with a secondary code of HLAMAIAH, Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology). Its NAICS code is 325414 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales